Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for ClearPoint Neuro Inc. (CLPT:NASDAQ), powered by AI.
ClearPoint Neuro Inc. is currently trading at $13.44. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for ClearPoint Neuro Inc. on Alpha Lenz.
View ClearPoint Neuro Inc.'s valuation metrics on Alpha Lenz.
“ClearPoint Neuro Inc.'s ROE is -95.6%. Explore profitability and growth together.”
Ask for details →ClearPoint Neuro Inc. is an innovative medical device company that specializes in the development and commercialization of platform tech aimed at navigating the brain. Primarily, it focuses on providing real-time MRI-guided systems that enhance the precision and safety of interventions in neurological surgeries. These systems are designed to facilitate a range of procedures, including biopsies, tumor resection, and the delivery of therapeutics directly into the brain. By offering products that integrate seamlessly with existing MRI machinery, ClearPoint Neuro Inc. significantly impacts sectors like healthcare and neuroscience, providing vital tools to enhance surgical accuracy and patient outcomes. Positioned at the intersection of technology and medicine, ClearPoint Neuro holds a pivotal role in the marketplace for advanced medical solutions, aiding in the progress of precision medicine and expanding the possibilities for treatments of neurological conditions.
“ClearPoint Neuro Inc.'s ROE is -95.6%. Explore profitability and growth together.”
Ask for details →ClearPoint Neuro Inc. (ticker: CLPT) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 115 employees.
The current price is $13.44 with a P/E ratio of -x and P/B of -x.
ROE is -95.64% and operating margin is -65.36%. Annual revenue is $37M.